Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencySun, 02 Jun 2024 05:15:52 +0200Tue, 07 May 2024 15:00:00 +0200Human medicines European public assessment report (EPAR): Vaxzevria (previously COVID-19 Vaccine AstraZeneca), COVID-19 Vaccine (ChAdOx1-S [recombinant]), Date of authorisation: 29/01/2021, Revision: 32, Status: Withdrawnhttps://www.ema.europa.eu/en/medicines/human/EPAR/vaxzevria-previously-covid-19-vaccine-astrazenecaHuman medicines European public assessment report (EPAR): Vaxzevria (previously COVID-19 Vaccine AstraZeneca), COVID-19 Vaccine (ChAdOx1-S [recombinant]), Date of authorisation: 29/01/2021, Revision: 32, Status: Withdrawnhttps://www.ema.europa.eu/en/medicines/human/EPAR/vaxzevria-previously-covid-19-vaccine-astrazenecaTue, 07 May 2024 15:00:00 +0200Human medicineVaxzevria (previously COVID-19 Vaccine AstraZeneca) : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/vaxzevria-previously-covid-19-vaccine-astrazeneca-epar-product-information_en.pdfVaxzevria (previously COVID-19 Vaccine AstraZeneca) : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/vaxzevria-previously-covid-19-vaccine-astrazeneca-epar-product-information_en.pdfTue, 07 May 2024 12:41:00 +0200Human medicine